A detailed history of Quest Partners LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 2,203 shares of EWTX stock, worth $54,171. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,203
Previous 9,035 75.62%
Holding current value
$54,171
Previous $241 Million 75.61%
% of portfolio
0.01%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

SELL
$26.63 - $36.62 $181,936 - $250,187
-6,832 Reduced 75.62%
2,203 $58.8 Million
Q3 2024

Nov 07, 2024

BUY
$15.88 - $29.5 $115,812 - $215,143
7,293 Added 418.66%
9,035 $241 Million
Q2 2024

Aug 06, 2024

BUY
$15.08 - $21.23 $16,045 - $22,588
1,064 Added 156.93%
1,742 $31.4 Million
Q1 2024

May 09, 2024

BUY
$9.25 - $19.97 $6,271 - $13,539
678 New
678 $12.4 Million

Others Institutions Holding EWTX

About Edgewise Therapeutics, Inc.


  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $1.55B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.